RTP company lands work with AstraZeneca
November 28, 2017 at 14:56 PM EST
Research Triangle Park-based G1 Therapeutics – which raised more than $108 million in its initial public offering earlier this year – has landed work with global biopharmaceutical behemoth AstraZeneca.
